DBCO-PEG1-OH

DBCO-PEG2-C2-acid is a heterobifunctional linker used in constructing Antibody-Drug Conjugates (ADCs) for targeted cancer therapy research. Its DBCO group enables efficient, copper-free click chemistry conjugation to azide-modified antibodies, facilitating the development of ADCs for both in vitro and in vivo preclinical studies.